Lista de obras -

A borderline range for Quantiferon Gold In-Tube results.

artículo científico publicado en 2017

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis

artículo científico publicado en 2011

A new mathematical model to identify contacts with recent and remote latent tuberculosis.

artículo científico publicado en 2019

A sensitive urinary lipoarabinomannan test for tuberculosis

artículo científico publicado en 2015

African 2, a Clonal Complex of Mycobacterium bovis Epidemiologically Important in East Africa

artículo científico publicado en 2012

African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa

artículo científico publicado en 2010

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

artículo científico

Biomarkers for tuberculosis: the case for lipoarabinomannan

artículo científico publicado en 2019

Comparison between RFLP and MIRU-VNTR genotyping of Mycobacterium tuberculosis strains isolated in Stockholm 2009 to 2011.

artículo científico publicado en 2014

Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection

artículo científico publicado en 2011

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study

artículo científico publicado en 2019

Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting

artículo científico publicado en 2018

Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden

artículo científico publicado en 2010

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

artículo científico publicado en 2017

Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics

artículo científico publicado en 2002

Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

artículo científico publicado en 2016

Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in Sweden

artículo científico publicado en 2011

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

artículo científico publicado en 2019

Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker

artículo científico publicado en 2012

Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis

artículo científico publicado en 2002

Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China

scientific article published on 27 April 2020

Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden

artículo científico publicado en 2020

Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis

scientific article published on 25 July 2019

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

artículo científico publicado en 2015

Minimum inhibitory concentrations of fluoroquinolones and pyrazinamide susceptibility correlate to clinical improvement in MDR-TB patients - a nationwide Swedish cohort study over two decades

artículo científico publicado en 2019

Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection

artículo científico publicado en 2002

Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia

artículo científico publicado en 2003

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

artículo científico publicado en 2018

Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay

artículo científico publicado en 2018

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

article

Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia

artículo científico publicado en 2007

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

scientific article published on 16 June 2020

Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden

scientific article published on 24 October 2019

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study

artículo científico publicado en 2014

Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis

artículo científico publicado en 2018

Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017

artículo científico publicado en 2020

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

scientific article published on 03 April 2019

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

artículo científico publicado en 2019

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

artículo científico publicado en 2015

Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis

artículo científico publicado en 2017

Towards tuberculosis elimination: an action framework for low-incidence countries

artículo científico publicado en 2015

Treatment of latent tuberculosis with 12-weeks isoniazid/rifapentine in clinical practice

scientific article published on 07 February 2019

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

artículo científico publicado en 2020

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study

artículo científico publicado en 2018

Tuberculosis and HIV Coinfection

artículo científico publicado en 2015

Lista de obras de

A borderline range for Quantiferon Gold In-Tube results.

A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis

A new mathematical model to identify contacts with recent and remote latent tuberculosis.

A sensitive urinary lipoarabinomannan test for tuberculosis

African 2, a Clonal Complex of Mycobacterium bovis Epidemiologically Important in East Africa

African 2, a clonal complex of Mycobacterium bovis epidemiologically important in East Africa

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

Biomarkers for tuberculosis: the case for lipoarabinomannan

Comparison between RFLP and MIRU-VNTR genotyping of Mycobacterium tuberculosis strains isolated in Stockholm 2009 to 2011.

Detection of proliferative responses to ESAT-6 and CFP-10 by FASCIA assay for diagnosis of Mycobacterium tuberculosis infection

Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study

Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting

Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Evaluation of outpatients with suspected pulmonary tuberculosis in a high HIV prevalence setting in Ethiopia: clinical, diagnostic and epidemiological characteristics

Fixed-dose combination and therapeutic drug monitoring in tuberculosis: friend or foe?

Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in Sweden

Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker

Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis

Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China

Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden

Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosis

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

Minimum inhibitory concentrations of fluoroquinolones and pyrazinamide susceptibility correlate to clinical improvement in MDR-TB patients - a nationwide Swedish cohort study over two decades

Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection

Occurrence of Pneumocystis carinii in HIV-positive patients with suspected pulmonary tuberculosis in Ethiopia

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

Plasma Levels of Rifampin Correlate with the Tuberculosis Drug Activity Assay

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study

Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

Quality of life of patients on treatment for latent tuberculosis infection: a mixed-method study in Stockholm, Sweden

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study

Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis

Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

Therapeutic drug monitoring to prevent acquired drug resistance of fluoroquinolones in the treatment of tuberculosis

Towards tuberculosis elimination: an action framework for low-incidence countries

Treatment of latent tuberculosis with 12-weeks isoniazid/rifapentine in clinical practice

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study

Tuberculosis and HIV Coinfection